• Home
  • Politics
  • Health
  • World
  • Business
  • Finance
  • Tech
  • More
    • Sports
    • Entertainment
    • Lifestyle
What's Hot

Trump Announces First Post-Tariff Trade Deal

May 8, 2025

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025

Top 10 Benefits Of Acupuncture

May 8, 2025
Facebook Twitter Instagram
  • Contact
  • Privacy Policy
  • Terms & Conditions
Friday, May 9
Patriot Now NewsPatriot Now News
  • Home
  • Politics

    Security video shows brazen sexual assault of California woman by homeless man

    October 24, 2023

    Woman makes disturbing discovery after her boyfriend chases away home intruder who stabbed him

    October 24, 2023

    Poll finds Americans overwhelmingly support Israel’s war on Hamas, but younger Americans defend Hamas

    October 24, 2023

    Off-duty pilot charged with 83 counts of attempted murder after allegedly trying to shut off engines midflight on Alaska Airlines

    October 23, 2023

    Leaked audio of Shelia Jackson Lee abusively cursing staffer

    October 22, 2023
  • Health

    Disparities In Cataract Care Are A Sorry Sight

    October 16, 2023

    Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

    October 16, 2023

    Long-term steroid use should be a last resort

    October 16, 2023

    Rite Aid Files For Bankruptcy With More ‘Underperforming Stores’ To Close

    October 16, 2023

    Who’s Still Dying From Complications Related To Covid-19?

    October 16, 2023
  • World

    New York Democrat Dan Goldman Accuses ‘Conservatives in the South’ of Holding Rallies with ‘Swastikas’

    October 13, 2023

    IDF Ret. Major General Describes Rushing to Save Son, Granddaughter During Hamas Invasion

    October 13, 2023

    Black Lives Matter Group Deletes Tweet Showing Support for Hamas 

    October 13, 2023

    AOC Denounces NYC Rally Cheering Hamas Terrorism: ‘Unacceptable’

    October 13, 2023

    L.A. Prosecutors Call Out Soros-Backed Gascón for Silence on Israel

    October 13, 2023
  • Business

    Trump Announces First Post-Tariff Trade Deal

    May 8, 2025

    Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

    May 7, 2025

    Tyson Foods Announces It Will Bend The Knee To Trump Admin’s New Rules

    May 7, 2025

    Federal Reserve Holds Interest Rates Steady Despite Pressure From Trump

    May 7, 2025

    ‘Wait Them Out’: John Kennedy Tells Larry Kudlow One Lie He Suspects China’s Telling US

    May 7, 2025
  • Finance

    Ending China’s De Minimis Exception Brings 3 Benefits for Americans

    April 17, 2025

    The Trump Tariff Shock Should Push Indonesia to Reform Its Economy

    April 17, 2025

    Tariff Talks an Opportunity to Reinvigorate the Japan-US Alliance

    April 17, 2025

    How China’s Companies Are Responding to the US Trade War

    April 16, 2025

    The US Flip-flop Over H20 Chip Restrictions 

    April 16, 2025
  • Tech

    Cruz Confronts Zuckerberg on Pointless Warning for Child Porn Searches

    February 2, 2024

    FTX Abandons Plans to Relaunch Crypto Exchange, Commits to Full Repayment of Customers and Creditors

    February 2, 2024

    Elon Musk Proposes Tesla Reincorporates in Texas After Delaware Judge Voids Pay Package

    February 2, 2024

    Tesla’s Elon Musk Tops Disney’s Bob Iger as Most Overrated Chief Executive

    February 2, 2024

    Mark Zuckerberg’s Wealth Grew $84 Billion in 2023 as Pedophiles Target Children on Facebook, Instagram

    February 2, 2024
  • More
    • Sports
    • Entertainment
    • Lifestyle
Patriot Now NewsPatriot Now News
Home»Finance»GILD Stock: Gilead Plots A Massive Move Into Oncology With A Third Of Sales By 2030
Finance

GILD Stock: Gilead Plots A Massive Move Into Oncology With A Third Of Sales By 2030

August 5, 2023No Comments4 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
GILD Stock: Gilead Plots A Massive Move Into Oncology With A Third Of Sales By 2030
Share
Facebook Twitter LinkedIn Pinterest Email

Gilead Sciences (GILD) expects a third of sales to come from its cancer treatments by 2030, and GILD stock jumped Friday despite a mixed earnings report.




X



Sales of Trodelvy, Yescarta and Tecartus — Gilead’s cancer drugs — surged a combined 38% to $728 million. That beat analyst expectations for $709 million, according to FactSet. RBC Capital Markets analyst Brian Abrahams says Gilead continues to see strong adoption for its HIV and cancer drugs.

“This should continue to provide valuation support and limit downside risk while the company’s broader pivot into cancer (drugs) in the coming years, though meaningful near-term upside may also be capped by limited pipeline catalysts and upcoming competitor datasets,” he said in a note to clients.

On today’s stock market, GILD stock jumped 4.2% to close at 78.68.

GILD Stock: Veklury Weighs On Growth

Total second-quarter sales climbed 5% to $6.6 billion, above analyst forecasts for $6.45 billion. Excluding the impact of Gilead’s Covid treatment, Veklury, total sales jumped 11%. Veklury sales tumbled 43% to $256 million. That was far short of projections for $354 million.

Further, adjusted earnings tumbled 15% to $1.34 per share and missed predictions for $1.64 a share. Third Bridge analyst Lee Brown noted the earnings miss is primarily due to a 32-cent charge related to an HIV treatment antitrust case.

Still, “there were several standout performances in the quarter, including Biktarvy, Descovy and Trodelvy,” Brown said in his note to clients. “Conversely, Yescarta and Tecartus generated strong growth, but still fell shy of (analyst) expectations.”

Biktarvy, an HIV treatment, brought in $2.98 billion in sales, above calls for $2.88 billion. Sales jumped 17%. Revenue from fellow HIV drug Descovy rose 12% to $516 million, beating GILD stock analysts’ view for $493 million.

See also  How Vietnam Can Disrupt China’s Dominance in EVs

“As HIV drug Biktarvy goes, so goes Gilead given the drug generated 45% of Gilead’s total revenue in the second quarter,” Brown said. “Fortunately for Gilead, Biktarvy appears to be firing on all cylinders.”

Cancer Treatments ‘On Track’

Sales from breast cancer treatment Trodelvy skyrocketed 63% to $260 million. Gilead noted increased adoption among patients with a specific form of metastatic breast cancer. Analysts predicted just $243 million in Trodelvy sales.

Cell therapies Yescarta and Tecartus generated a respective $380 million and $88 million in sales. Yescarta sales jumped 29% and beat expectations for $375 million, according to FactSet. But Third Bridge’s Brown said other estimates suggested Yescarta sales could come in higher.

Meanwhile, Tecartus sales rose 21% but were just shy of analyst forecasts for $91 million.

Gilead management believes the company is “on track” for have a third of revenue come from cancer treatments by 2030, Mizuho Securities analyst Salim Syed said. To achieve that goal, Gilead could look for partnership, licensing or buyout deals.

“Management plans to continue to be active in business development, potentially including oncology,” he said in a note. “The focus could be predominantly partnerships and smaller acquisitions — Gilead’s ‘base case’ expectation.”

Gilead Boosts Its Sales Outlook

Gilead slightly raised its sales outlook for the year, while trimming its adjusted earnings forecast.

The company now expects full-year sales to come in at $26.3 billion to $26.7 billion. GILD stock analysts call for $26.67 billion in sales.

Gilead now expects to earn $6.45-$6.80 per share vs. its previous call for $6.60-$7 a share. The Street forecasts Gilead earnings of $6.72 per share. The company noted part of its decision to lower its profit outlook is related to the HIV antitrust litigation.

See also  Beyoncé Kicks Off Renaissance World Tour with Massive Trans Flag

Follow Allison Gatlin on Twitter at @IBD_AGatlin.

YOU MAY ALSO LIKE:

The Unexpectedly Good News That Helped Regeneron Retake Its 200-Day Line

Moderna’s Game Over? Not Quite, As Company Boosts Its 2023 Outlook

IBD Stock Of The Day: See How To Find, Track And Buy The Best Stocks

Watch IBD’s Investing Strategies Show For Actionable Market Insights

Short-Term Trades Can Add Up To Big Profits. IBD’s SwingTrader Shows You How

GILD Gilead Massive move Oncology plots sales stock
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

May 7, 2025

Amazon Reportedly Floats Plan To Show Tariff Price Increases To Shoppers — Karoline Leavitt Calls It ‘Hostile’ Move

April 29, 2025

‘Strong And Clear Message’: European Bureaucrats Slap American Tech Giants With Massive Fines

April 23, 2025

Ending China’s De Minimis Exception Brings 3 Benefits for Americans

April 17, 2025
Add A Comment

Leave A Reply Cancel Reply

Top Posts

Netflix Dedicates a Season of Dating Show ‘The Ultimatum’ to All LGBTQIA2S+ Contestants

April 27, 2023

Hollywood mansion worth millions gets trashed by squatters: ‘F*** rich people’

August 12, 2023

Buddy Matthews reacts to Rhea Ripley’s photo which broke the internet, she responds

August 5, 2023

Disgraced Democrat operative’s teen son arrested; allegedly threatened to ‘shoot up’ his former middle school

April 9, 2023
Don't Miss

Trump Announces First Post-Tariff Trade Deal

Business May 8, 2025

President Donald Trump announced Thursday the U.S. has reached a trade agreement with the U.K.,…

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025

Top 10 Benefits Of Acupuncture

May 8, 2025

Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

May 7, 2025
About
About

This is your World, Tech, Health, Entertainment and Sports website. We provide the latest breaking news straight from the News industry.

We're social. Connect with us:

Facebook Twitter Instagram Pinterest
Categories
  • Business (4,110)
  • Entertainment (4,220)
  • Finance (3,202)
  • Health (1,938)
  • Lifestyle (1,626)
  • Politics (3,084)
  • Sports (4,036)
  • Tech (2,006)
  • Uncategorized (4)
  • World (3,944)
Our Picks

The APEC Summit Is Happening in San Francisco. What Is APEC, Anyway?

November 13, 2023

Can Natural Edibles Boost Your Mood And Mind?

May 31, 2024

Police On Horseback Chase Down Driver Using Phone At Wheel In UK

March 17, 2023
Popular Posts

Trump Announces First Post-Tariff Trade Deal

May 8, 2025

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025

Top 10 Benefits Of Acupuncture

May 8, 2025
© 2025 Patriotnownews.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.